Lixisenatide0 vendors competing
No vendor pricing available for this peptide yet.
Research details
Lixisenatide — research data
Regulatory statusFDA-approved (Adlyxin)
NCAA D1Not listed
Overview
About Lixisenatide
Mechanism of action
Once-daily prandial GLP-1 receptor agonist
Safety profile
Nausea, headache, hypoglycemia risk · Approved for T2DM; GI side effects; well-characterized
Related pages